HomeBCAX • NASDAQ
add
Bicara Therapeutics Inc
Previous close
$25.70
Day range
$24.80 - $27.45
Year range
$21.05 - $27.91
Market cap
1.25B USD
Avg Volume
295.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.56M | 110.68% |
Net income | -14.78M | -76.99% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -17.55M | -110.56% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.86M | — |
Total assets | 208.78M | — |
Total liabilities | 16.28M | — |
Total equity | 192.50M | — |
Shares outstanding | 34.26M | — |
Price to book | -5.04 | — |
Return on assets | -21.03% | — |
Return on capital | -22.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -14.78M | -76.99% |
Cash from operations | -13.75M | -1.61% |
Cash from investing | 19.50K | — |
Cash from financing | 435.50K | -97.70% |
Net change in cash | -13.29M | -345.43% |
Free cash flow | -9.88M | — |
About
Founded
2018
Headquarters
Website
Employees
32
